Fezolinetant cuts hot flashes for almost 6 months
Fezolinetant 45 mg appears to be effective for up to 24 weeks in the treatment of moderate-to-severe vasomotor symptoms (VMS) associated with menopause in women who are considered… read more.
Fezolinetant 45 mg appears to be effective for up to 24 weeks in the treatment of moderate-to-severe vasomotor symptoms (VMS) associated with menopause in women who are considered… read more.
Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved… read more.
The study of a novel oral vaccine that could protect against chlamydia infection has been awarded approximately $11 million in National Institutes of Health funding over five years… read more.
Just a few days on a night shift schedule throws off protein rhythms related to blood glucose regulation, energy metabolism and inflammation, processes that can influence the development… read more.
Australian researchers have discovered how changes in antibody levels over time can predict which children are likely to outgrow their peanut allergy. The research, led by Murdoch Children’s Research… read more.
Medtronic announced it received approval from the National Medical Products Administration (NMPA) in China for its Symplicity Spyral renal denervation (RDN) system, also known as the Symplicity blood… read more.
As part of the University of Colorado Department of Medicine’s annual Research Day, held on April 23, faculty member Christine Swanson, MD, MCR, described her National Institutes of Health-funded clinical research on whether adequate… read more.
Most people with early-stage glaucoma don’t know they have it, even though early treatment is key to reducing vision loss. While detecting a subtle increase in eye pressure… read more.
Edwards Lifesciences announced the European launch of the SAPIEN 3 Ultra RESILIA valve, the only transcatheter aortic heart valve to incorporate the company’s breakthrough RESILIA tissue technology, designed… read more.
Your weekly digest of the top healthcare stories, covering news published from 06/05/2024 – 10/05/2024. Daily Telegraph One in 50 people is 95% likely to develop Alzheimer’s, a… read more.
On World Asthma Day 2024 the message is clear: “Asthma Education Empowers.” The Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, stresses the… read more.
Eyenovia announced results from a Phase IV study of Mydcombi designed to characterize the lowest deliverable dose for mydriasis (pupil dilation). Mydcombi is the only FDA-approved fixed dose… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.